|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1 to 100 out of 4043 for Mtor

<< First    < Previous  |  Next >    Last >>
0.047s

Categories

Hits by Pathway

Hits by Strain

Hits by Category

Type Details Score
Gene
324254 | mtor
Type: gene
Organism: zebrafish
•
•
•
•
•
Gene
100491970 | mtor
Type: gene
Organism: frog, western clawed
•
•
•
•
•
Gene
106992736 | MTOR
Type: gene
Organism: macaque, rhesus
•
•
•
•
•
Gene
2475 | MTOR
Type: gene
Organism: human
•
•
•
•
•
Gene
56718 | Mtor
Type: gene
Organism: rat
•
•
•
•
•
Gene
457945 | MTOR
Type: gene
Organism: chimpanzee
•
•
•
•
•
Gene
478232 | MTOR
Type: gene
Organism: dog, domestic
•
•
•
•
•
Gene
100139219 | MTOR
Type: gene
Organism: cattle
•
•
•
•
•
Gene
419455 | MTOR
Type: gene
Organism: chicken
•
•
•
•
•
Protein Coding Gene
MGI:1928394 | Mtor
Type: protein_coding_gene
Organism: mouse, laboratory
•
•
•
•
•
GXD Expression
GXD Expression
Probe: MGI:6755523
Assay Type: Immunohistochemistry
Annotation Date: 2021-09-01
Strength: Present
Sex: Not Specified
Emaps: EMAPS:160362
Pattern: Widespread
Stage: TS02
Assay Id: MGI:6755548
Age: embryonic day 1.0
Image: 7B mTOR
Note: Expression throughout embryo.
Specimen Label: 7B mTOR
Detected: true
Specimen Num: 1
•
•
•
•
•
GXD Expression
GXD Expression
Probe: MGI:6755523
Assay Type: Immunohistochemistry
Annotation Date: 2021-09-01
Strength: Present
Sex: Not Specified
Emaps: EMAPS:318643
Pattern: Widespread
Stage: TS03
Assay Id: MGI:6755548
Age: embryonic day 2.0
Image: 7C mTOR 4-c
Note: Expression throughout embryo.
Specimen Label: 7C mTOR 4-c
Detected: true
Specimen Num: 5
•
•
•
•
•
GXD Expression
GXD Expression
Probe: MGI:5796583
Assay Type: Immunohistochemistry
Annotation Date: 2022-11-15
Strength: Present
Sex: Male
Emaps: EMAPS:3284223
Pattern: Widespread
Stage: TS23
Assay Id: MGI:7384546
Age: embryonic day 15.5
Image: 5a mTOR WT
Note: Widely expressed throughout cortical primordium
Specimen Label: 5a mTOR WT
Detected: true
Specimen Num: 1
•
•
•
•
•
GXD Expression
GXD Expression
Probe: MGI:5796583
Assay Type: Immunohistochemistry
Annotation Date: 2022-11-15
Strength: Present
Sex: Male
Emaps: EMAPS:3284223
Pattern: Widespread
Stage: TS23
Assay Id: MGI:7384546
Age: embryonic day 15.5
Image: 5a mTOR Fmr1 KO
Note: No difference compared with wild type.
Specimen Label: 5a mTOR Fmr1 KO
Detected: true
Specimen Num: 2
•
•
•
•
•
GXD Expression
GXD Expression
Probe: MGI:6755523
Assay Type: Immunohistochemistry
Annotation Date: 2021-09-01
Strength: Present
Sex: Not Specified
Emaps: EMAPS:318653
Pattern: Widespread
Stage: TS03
Assay Id: MGI:6755548
Age: embryonic day 2.5
Image: 7C mTOR 8-c
Note: Expression throughout embryo.
Specimen Label: 7C mTOR 8-c
Detected: true
Specimen Num: 6
•
•
•
•
•
GXD Expression
GXD Expression
 
Probe: MGI:6755523
Assay Type: Immunohistochemistry
Annotation Date: 2021-09-01
Strength: Present
Sex: Female
Emaps: EMAPS:3102528
Pattern: Widespread
Stage: TS28
Assay Id: MGI:6755548
Age: postnatal adult
Image: 7C mTOR Ooc
Specimen Label: 7C mTOR Ooc
Detected: true
Specimen Num: 2
•
•
•
•
•
GXD Expression
GXD Expression
Probe: MGI:6755523
Assay Type: Immunohistochemistry
Annotation Date: 2021-09-01
Strength: Present
Sex: Not Specified
Emaps: EMAPS:160362
Pattern: Widespread
Stage: TS02
Assay Id: MGI:6755548
Age: embryonic day 1.0
Image: 7C mTOR 2-c
Note: Expression throughout embryo.
Specimen Label: 7C mTOR 2-c
Detected: true
Specimen Num: 4
•
•
•
•
•
GXD Expression
GXD Expression
Probe: MGI:6755523
Assay Type: Immunohistochemistry
Annotation Date: 2021-09-01
Strength: Present
Sex: Not Specified
Emaps: EMAPS:160331
Pattern: Widespread
Stage: TS01
Assay Id: MGI:6755548
Age: embryonic day 0.5
Image: 7C mTOR 1-c
Note: Expression throughout embryo.
Specimen Label: 7C mTOR 1-c
Detected: true
Specimen Num: 3
•
•
•
•
•
GXD Expression
GXD Expression
Probe: MGI:6755523
Assay Type: Immunohistochemistry
Annotation Date: 2021-09-01
Strength: Present
Sex: Not Specified
Emaps: EMAPS:360354
Pattern: Widespread
Stage: TS04
Assay Id: MGI:6755548
Age: embryonic day 3.5
Image: 7C mTOR Blastocyst
Note: Expression throughout embryo.
Specimen Label: 7C mTOR Blastocyst
Detected: true
Specimen Num: 7
•
•
•
•
•
Publication
19487463 | J:151331
First Author: Acosta-Jaquez HA
Year: 2009
Journal: Mol Cell Biol
Title: Site-specific mTOR phosphorylation promotes mTORC1-mediated signaling and cell growth.
Volume: 29
Issue: 15
Pages: 4308-24
•
•
•
•
•
Publication
29750810 | J:263234
First Author: Ramanathan C
Year: 2018
Journal: PLoS Genet
Title: mTOR signaling regulates central and peripheral circadian clock function.
Volume: 14
Issue: 5
Pages: e1007369
•
•
•
•
•
Publication
18046414 | J:128527
First Author: Cunningham JT
Year: 2007
Journal: Nature
Title: mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex.
Volume: 450
Issue: 7170
Pages: 736-40
•
•
•
•
•
Publication
25336251 | J:225705
 
First Author: Scheffler JM
Year: 2014
Journal: Nat Commun
Title: LAMTOR2 regulates dendritic cell homeostasis through FLT3-dependent mTOR signalling.
Volume: 5
Pages: 5138
•
•
•
•
•
Gene
100873935 | MTOR-AS1
Type: gene
Organism: human
•
•
•
•
•
Publication
23027611 | J:215861
First Author: Meffre J
Year: 2012
Journal: EMBO Mol Med
Title: 5-HT(6) receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia.
Volume: 4
Issue: 10
Pages: 1043-56
•
•
•
•
•
Publication
28283069 | J:320286
First Author: Saxton RA
Year: 2017
Journal: Cell
Title: mTOR Signaling in Growth, Metabolism, and Disease.
Volume: 168
Issue: 6
Pages: 960-976
•
•
•
•
•
Publication
16962829 | J:119564
First Author: Shiota C
Year: 2006
Journal: Dev Cell
Title: Multiallelic disruption of the rictor gene in mice reveals that mTOR complex 2 is essential for fetal growth and viability.
Volume: 11
Issue: 4
Pages: 583-9
•
•
•
•
•
Publication
22500797 | J:319697
First Author: Laplante M
Year: 2012
Journal: Cell
Title: mTOR signaling in growth control and disease.
Volume: 149
Issue: 2
Pages: 274-93
•
•
•
•
•
Publication
21258367 | J:175316
First Author: Kim J
Year: 2011
Journal: Nat Cell Biol
Title: AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1.
Volume: 13
Issue: 2
Pages: 132-41
•
•
•
•
•
Publication
20801936 | J:164024
First Author: Takai H
Year: 2010
Journal: Genes Dev
Title: Tel2 structure and function in the Hsp90-dependent maturation of mTOR and ATR complexes.
Volume: 24
Issue: 18
Pages: 2019-30
•
•
•
•
•
Publication
37532788 | J:341188
First Author: Fan C
Year: 2023
Journal: Leukemia
Title: Kinase-independent role of mTOR and on-/off-target effects of an mTOR kinase inhibitor.
Volume: 37
Issue: 10
Pages: 2073-2081
•
•
•
•
•
Publication
19185849 | J:144810
First Author: Guertin DA
Year: 2009
Journal: Cancer Cell
Title: mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice.
Volume: 15
Issue: 2
Pages: 148-59
•
•
•
•
•
Publication
32289154 | J:288637
 
First Author: Ramalingam P
Year: 2020
Journal: J Exp Med
Title: Endothelial mTOR maintains hematopoiesis during aging.
Volume: 217
Issue: 6
•
•
•
•
•
Publication
19176516 | J:261276
First Author: Nardella C
Year: 2009
Journal: Sci Signal
Title: Differential requirement of mTOR in postmitotic tissues and tumorigenesis.
Volume: 2
Issue: 55
Pages: ra2
•
•
•
•
•
Publication
17141160 | J:137592
First Author: Guertin DA
Year: 2006
Journal: Dev Cell
Title: Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1.
Volume: 11
Issue: 6
Pages: 859-71
•
•
•
•
•
Publication
23716557 | J:205539
First Author: Guo F
Year: 2013
Journal: Haematologica
Title: Mouse gene targeting reveals an essential role of mTOR in hematopoietic stem cell engraftment and hematopoiesis.
Volume: 98
Issue: 9
Pages: 1353-8
•
•
•
•
•
Publication
23102618 | J:190892
First Author: Bayeva M
Year: 2012
Journal: Cell Metab
Title: mTOR regulates cellular iron homeostasis through tristetraprolin.
Volume: 16
Issue: 5
Pages: 645-57
•
•
•
•
•
Publication
33443202 | J:300033
 
First Author: Fan C
Year: 2021
Journal: Proc Natl Acad Sci U S A
Title: Adaptive responses to mTOR gene targeting in hematopoietic stem cells reveal a proliferative mechanism evasive to mTOR inhibition.
Volume: 118
Issue: 1
•
•
•
•
•
Gene
64223 | MLST8
Type: gene
Organism: human
•
•
•
•
•
Gene
57707 | MEAK7
Type: gene
Organism: human
•
•
•
•
•
Publication
29384525 | J:267927
First Author: Hassan Z
Year: 2018
Journal: Br J Cancer
Title: MTOR inhibitor-based combination therapies for pancreatic cancer.
Volume: 118
Issue: 3
Pages: 366-377
•
•
•
•
•
Publication
24717934 | J:310016
First Author: Morran DC
Year: 2014
Journal: Gut
Title: Targeting mTOR dependency in pancreatic cancer.
Volume: 63
Issue: 9
Pages: 1481-9
•
•
•
•
•
Publication
37979583 | J:343575
First Author: Ge MK
Year: 2023
Journal: Cell Metab
Title: The tRNA-GCN2-FBXO22-axis-mediated mTOR ubiquitination senses amino acid insufficiency.
Volume: 35
Issue: 12
Pages: 2216-2230.e8
•
•
•
•
•
Publication
21512002 | J:172208
First Author: Narita M
Year: 2011
Journal: Science
Title: Spatial coupling of mTOR and autophagy augments secretory phenotypes.
Volume: 332
Issue: 6032
Pages: 966-70
•
•
•
•
•
Publication
34309874 | J:317932
First Author: Jiao L
Year: 2021
Journal: J Pathol
Title: Deletion of mTOR in liver epithelial cells enhances hepatic metastasis of colon cancer.
Volume: 255
Issue: 3
Pages: 270-284
•
•
•
•
•
Publication
29625033 | J:262039
First Author: Jia J
Year: 2018
Journal: Mol Cell
Title: Galectins Control mTOR in Response to Endomembrane Damage.
Volume: 70
Issue: 1
Pages: 120-135.e8
•
•
•
•
•
Publication
27340174 | J:233300
First Author: Smithson LJ
Year: 2016
Journal: Genes Dev
Title: Proteomic analysis reveals GIT1 as a novel mTOR complex component critical for mediating astrocyte survival.
Volume: 30
Issue: 12
Pages: 1383-8
•
•
•
•
•
Publication
27880763 | J:242988
First Author: Bulut-Karslioglu A
Year: 2016
Journal: Nature
Title: Inhibition of mTOR induces a paused pluripotent state.
Volume: 540
Issue: 7631
Pages: 119-123
•
•
•
•
•
Publication
23538752 | J:201860
First Author: Guo F
Year: 2013
Journal: Leukemia
Title: mTOR regulates DNA damage response through NF-κB-mediated FANCD2 pathway in hematopoietic cells.
Volume: 27
Issue: 10
Pages: 2040-2046
•
•
•
•
•
Publication
20670887 | J:163259
First Author: Düvel K
Year: 2010
Journal: Mol Cell
Title: Activation of a metabolic gene regulatory network downstream of mTOR complex 1.
Volume: 39
Issue: 2
Pages: 171-83
•
•
•
•
•
Publication
15485918 | J:94133
First Author: Gangloff YG
Year: 2004
Journal: Mol Cell Biol
Title: Disruption of the mouse mTOR gene leads to early postimplantation lethality and prohibits embryonic stem cell development.
Volume: 24
Issue: 21
Pages: 9508-16
•
•
•
•
•
Publication
27524416 | J:305118
First Author: Chen R
Year: 2017
Journal: Oncogene
Title: mTOR promotes pituitary tumor development through activation of PTTG1.
Volume: 36
Issue: 7
Pages: 979-988
•
•
•
•
•
Publication
29720621 | J:263661
First Author: Zhu C
Year: 2018
Journal: Sci Rep
Title: mTOR complexes differentially orchestrates eosinophil development in allergy.
Volume: 8
Issue: 1
Pages: 6883
•
•
•
•
•
Publication
22193387 | J:184667
First Author: Cinà DP
Year: 2012
Journal: J Am Soc Nephrol
Title: Inhibition of MTOR disrupts autophagic flux in podocytes.
Volume: 23
Issue: 3
Pages: 412-20
•
•
•
•
•
Publication
29567716 | J:261780
First Author: Terenzio M
Year: 2018
Journal: Science
Title: Locally translated mTOR controls axonal local translation in nerve injury.
Volume: 359
Issue: 6382
Pages: 1416-1421
•
•
•
•
•
Publication
28381544 | J:242296
First Author: Li R
Year: 2017
Journal: Cancer Res
Title: Modulation of Bax and mTOR for Cancer Therapeutics.
Volume: 77
Issue: 11
Pages: 3001-3012
•
•
•
•
•
Publication
23129577 | J:316435
First Author: Carr TD
Year: 2012
Journal: Cancer Prev Res (Phila)
Title: Inhibition of mTOR suppresses UVB-induced keratinocyte proliferation and survival.
Volume: 5
Issue: 12
Pages: 1394-404
•
•
•
•
•
Publication
27067005 | J:305358
First Author: Chen F
Year: 2016
Journal: J Immunol
Title: mTOR Mediates IL-23 Induction of Neutrophil IL-17 and IL-22 Production.
Volume: 196
Issue: 10
Pages: 4390-9
•
•
•
•
•
Publication
21750711 | J:176072
First Author: Yu J
Year: 2011
Journal: PLoS One
Title: mTOR controls ovarian follicle growth by regulating granulosa cell proliferation.
Volume: 6
Issue: 7
Pages: e21415
•
•
•
•
•
Publication
22561297 | J:189057
First Author: Aoyagi T
Year: 2012
Journal: Am J Physiol Heart Circ Physiol
Title: Cardiac mTOR protects the heart against ischemia-reperfusion injury.
Volume: 303
Issue: 1
Pages: H75-85
•
•
•
•
•
Publication
27819329 | J:259561
 
First Author: Shan L
Year: 2016
Journal: Sci Rep
Title: mTOR Overactivation in Mesenchymal cells Aggravates CCl4- Induced liver Fibrosis.
Volume: 6
Pages: 36037
•
•
•
•
•
Publication
32282093 | J:301777
First Author: Pan X
Year: 2020
Journal: FASEB J
Title: Accumulation of prelamin A induces premature aging through mTOR overactivation.
Volume: 34
Issue: 6
Pages: 7905-7914
•
•
•
•
•
Publication
32917361 | J:304752
First Author: Tokumura K
Year: 2020
Journal: Biochem Biophys Res Commun
Title: mTOR regulates skeletogenesis through canonical and noncanonical pathways.
Volume: 533
Issue: 1
Pages: 30-35
•
•
•
•
•
Publication
29555746 | J:261082
First Author: Liu D
Year: 2018
Journal: Proc Natl Acad Sci U S A
Title: mTOR signaling in VIP neurons regulates circadian clock synchrony and olfaction.
Volume: 115
Issue: 14
Pages: E3296-E3304
•
•
•
•
•
Publication
21310925 | J:172837
First Author: Gorentla BK
Year: 2011
Journal: Blood
Title: Negative regulation of mTOR activation by diacylglycerol kinases.
Volume: 117
Issue: 15
Pages: 4022-31
•
•
•
•
•
Publication
19356717 | J:148167
First Author: Mori H
Year: 2009
Journal: Cell Metab
Title: Critical role for hypothalamic mTOR activity in energy balance.
Volume: 9
Issue: 4
Pages: 362-74
•
•
•
•
•
Publication
24481314 | J:206952
First Author: Khapre RV
Year: 2014
Journal: Aging (Albany NY)
Title: BMAL1-dependent regulation of the mTOR signaling pathway delays aging.
Volume: 6
Issue: 1
Pages: 48-57
•
•
•
•
•
Publication
19733540 | J:154125
First Author: Castilho RM
Year: 2009
Journal: Cell Stem Cell
Title: mTOR mediates Wnt-induced epidermal stem cell exhaustion and aging.
Volume: 5
Issue: 3
Pages: 279-89
•
•
•
•
•
Publication
23454868 | J:267894
First Author: Liu Y
Year: 2013
Journal: Aging (Albany NY)
Title: Temporal mTOR inhibition protects Fbxw7-deficient mice from radiation-induced tumor development.
Volume: 5
Issue: 2
Pages: 111-9
•
•
•
•
•
Publication
30318987 | J:295690
First Author: Xu Z
Year: 2019
Journal: Adipocyte
Title: Elucidating the role of Lkb1 and mTOR in adipose tissue.
Volume: 8
Issue: 1
Pages: 26-30
•
•
•
•
•
Publication
19934433 | J:260384
First Author: Chen C
Year: 2009
Journal: Sci Signal
Title: mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells.
Volume: 2
Issue: 98
Pages: ra75
•
•
•
•
•
Publication
26631481 | J:230899
First Author: Sampson LL
Year: 2016
Journal: FASEB J
Title: mTOR disruption causes intestinal epithelial cell defects and intestinal atrophy postinjury in mice.
Volume: 30
Issue: 3
Pages: 1263-75
•
•
•
•
•
Publication
26598511 | J:252582
First Author: Shende P
Year: 2016
Journal: Cardiovasc Res
Title: Cardiac mTOR complex 2 preserves ventricular function in pressure-overload hypertrophy.
Volume: 109
Issue: 1
Pages: 103-14
•
•
•
•
•
Publication
26416965 | J:227652
First Author: Bao Y
Year: 2015
Journal: J Cell Biol
Title: mTOR and differential activation of mitochondria orchestrate neutrophil chemotaxis.
Volume: 210
Issue: 7
Pages: 1153-64
•
•
•
•
•
Publication
26418749 | J:309334
First Author: Wu M
Year: 2015
Journal: Oncotarget
Title: Flcn-deficient renal cells are tumorigenic and sensitive to mTOR suppression.
Volume: 6
Issue: 32
Pages: 32761-73
•
•
•
•
•
Publication
25273085 | J:217495
First Author: Ka M
Year: 2014
Journal: Development
Title: mTOR regulates brain morphogenesis by mediating GSK3 signaling.
Volume: 141
Issue: 21
Pages: 4076-86
•
•
•
•
•
Publication
27760048 | J:239616
First Author: Jones DD
Year: 2016
Journal: J Clin Invest
Title: mTOR has distinct functions in generating versus sustaining humoral immunity.
Volume: 126
Issue: 11
Pages: 4250-4261
•
•
•
•
•
Publication
19258318 | J:149848
First Author: Ganley IG
Year: 2009
Journal: J Biol Chem
Title: ULK1.ATG13.FIP200 complex mediates mTOR signaling and is essential for autophagy.
Volume: 284
Issue: 18
Pages: 12297-305
•
•
•
•
•
Publication
30843872 | J:285885
   
First Author: Li J
Year: 2019
Journal: JCI Insight
Title: Myeloid Folliculin balances mTOR activation to maintain innate immunity homeostasis.
Volume: 5
•
•
•
•
•
Publication
28592812 | J:274163
First Author: Wang A
Year: 2017
Journal: Sci Rep
Title: Activity-independent targeting of mTOR to lysosomes in primary osteoclasts.
Volume: 7
Issue: 1
Pages: 3005
•
•
•
•
•
Publication
15963500 | J:100939
First Author: Park IH
Year: 2005
Journal: Exp Cell Res
Title: Skeletal myocyte hypertrophy requires mTOR kinase activity and S6K1.
Volume: 309
Issue: 1
Pages: 211-9
•
•
•
•
•
Publication
21613414 | J:175260
First Author: Buller CL
Year: 2011
Journal: Am J Physiol Renal Physiol
Title: GLUT1 enhances mTOR activity independently of TSC2 and AMPK.
Volume: 301
Issue: 3
Pages: F588-96
•
•
•
•
•
Publication
28569781 | J:317242
First Author: Rinaldi L
Year: 2017
Journal: Cell Death Dis
Title: Mitochondrial AKAP1 supports mTOR pathway and tumor growth.
Volume: 8
Issue: 6
Pages: e2842
•
•
•
•
•
Publication
23858034 | J:205684
First Author: Zhang S
Year: 2013
Journal: J Immunol
Title: B cell-specific deficiencies in mTOR limit humoral immune responses.
Volume: 191
Issue: 4
Pages: 1692-703
•
•
•
•
•
Publication
25385646 | J:216282
First Author: Limon JJ
Year: 2014
Journal: Proc Natl Acad Sci U S A
Title: mTOR kinase inhibitors promote antibody class switching via mTORC2 inhibition.
Volume: 111
Issue: 47
Pages: E5076-85
•
•
•
•
•
Publication
28356345 | J:247845
First Author: Li Z
Year: 2017
Journal: FASEB J
Title: mTOR activation protects liver from ischemia/reperfusion-induced injury through NF-κB pathway.
Volume: 31
Issue: 7
Pages: 3018-3026
•
•
•
•
•
Publication
19497867 | J:150064
First Author: Cybulski N
Year: 2009
Journal: Proc Natl Acad Sci U S A
Title: mTOR complex 2 in adipose tissue negatively controls whole-body growth.
Volume: 106
Issue: 24
Pages: 9902-7
•
•
•
•
•
Publication
22227194 | J:181222
First Author: Takahashi Y
Year: 2012
Journal: Biochem Biophys Res Commun
Title: The late endosome/lysosome-anchored p18-mTORC1 pathway controls terminal maturation of lysosomes.
Volume: 417
Issue: 4
Pages: 1151-7
•
•
•
•
•
Publication
28759045 | J:250666
First Author: Fujishita T
Year: 2017
Journal: Oncogene
Title: Tumor microenvironment confers mTOR inhibitor resistance in invasive intestinal adenocarcinoma.
Volume: 36
Issue: 46
Pages: 6480-6489
•
•
•
•
•
Publication
36509146 | J:332849
First Author: Baskaran P
Year: 2023
Journal: J Biol Chem
Title: Phosphorylation of the novel mTOR substrate Unkempt regulates cellular morphogenesis.
Volume: 299
Issue: 1
Pages: 102788
•
•
•
•
•
Publication
25060812 | J:215671
First Author: Dai J
Year: 2014
Journal: Glia
Title: Interaction of mTOR and Erk1/2 signaling to regulate oligodendrocyte differentiation.
Volume: 62
Issue: 12
Pages: 2096-109
•
•
•
•
•
Publication
32039915 | J:297795
First Author: Li G
Year: 2020
Journal: J Clin Invest
Title: Chronic mTOR activation induces a degradative smooth muscle cell phenotype.
Volume: 130
Issue: 3
Pages: 1233-1251
•
•
•
•
•
Publication
22179112 | J:181565
First Author: Subramaniam S
Year: 2011
Journal: Nat Neurosci
Title: Rhes, a striatal-enriched small G protein, mediates mTOR signaling and L-DOPA-induced dyskinesia.
Volume: 15
Issue: 2
Pages: 191-3
•
•
•
•
•
Publication
23624629 | J:198951
First Author: Zhu Y
Year: 2013
Journal: Am J Physiol Heart Circ Physiol
Title: Regulation of fatty acid metabolism by mTOR in adult murine hearts occurs independently of changes in PGC-1α.
Volume: 305
Issue: 1
Pages: H41-51
•
•
•
•
•
Publication
21358638 | J:170683
First Author: Delgoffe GM
Year: 2011
Journal: Nat Immunol
Title: The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2.
Volume: 12
Issue: 4
Pages: 295-303
•
•
•
•
•
Publication
28576773 | J:242899
First Author: Sinagoga KL
Year: 2017
Journal: Development
Title: Distinct roles for the mTOR pathway in postnatal morphogenesis, maturation and function of pancreatic islets.
Volume: 144
Issue: 13
Pages: 2402-2414
•
•
•
•
•
Publication
19622833 | J:248694
First Author: Santini E
Year: 2009
Journal: Sci Signal
Title: Inhibition of mTOR signaling in Parkinson's disease prevents L-DOPA-induced dyskinesia.
Volume: 2
Issue: 80
Pages: ra36
•
•
•
•
•
Publication
23818585 | J:198805
First Author: Shen C
Year: 2013
Journal: Proc Natl Acad Sci U S A
Title: The mTOR pathway negatively controls ATM by up-regulating miRNAs.
Volume: 110
Issue: 29
Pages: 11869-74
•
•
•
•
•
Publication
24036451 | J:201730
First Author: Kamano Y
Year: 2013
Journal: FEBS Lett
Title: PIH1D1 interacts with mTOR complex 1 and enhances ribosome RNA transcription.
Volume: 587
Issue: 20
Pages: 3303-8
•
•
•
•
•
Publication
28598226 | J:264664
First Author: Ka M
Year: 2017
Journal: Autophagy
Title: MTOR controls genesis and autophagy of GABAergic interneurons during brain development.
Volume: 13
Issue: 8
Pages: 1348-1363
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom